Peter Lynch · Growth at a reasonable price (GARP)
Is Indivior Pharmaceuticals Inc (INDV) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
71/100
Mitigé
2/6 critères validés
Les critères de Peter Lynch, appliqués à INDV
PEG ≤ 1.0
clé3.76
EPS CAGR ≥ 15%
clé5.0%
Revenue CAGR ≥ 10%
11.9%
Net margin > 0
19.4%
Comment INDV se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$4.21B
PER (TTM)
19.0x
ROIC (TTM)
85.68%
Marge brute
83.11%
Autres analyses Peter Lynch
Questions fréquentes
What is INDV's Peter Lynch fit score?
INDV scores 71/100 on our Peter Lynch fit engine. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own INDV?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends INDV.
How often is this score updated?
INDV's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Peter Lynch possède ou recommande INDV personnellement.
